Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3

Lignende værker

• Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3.
  af: Matilde Forcella, et al.
  Udgivet: (2017-01-01)
• Role of NEU3 Overexpression in the Prediction of Efficacy of EGFR-Targeted Therapies in Colon Cancer Cell Lines
  af: Bovio, Federica, et al.
  Udgivet: (2020)
• The role of Piccolo in cancer treatment: relationship with EGFR and related therapies, and a marker for new targeted therapies
  af: Frattini, Milo, et al.
  Udgivet: (2017)
• EGFR-TKI resistance in NSCLC patients: mechanisms and strategies
  af: Lin, Yuxin, et al.
  Udgivet: (2014)
• EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases
  af: Dong, Kai, et al.
  Udgivet: (2019)